Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms (Q47997349)
Jump to navigation
Jump to search
scientific article published in June 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms |
scientific article published in June 1998 |
Statements
Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms (English)
Jones H
Curtis VA
Wright P
Lucey JV
1 June 1998
155
6
838-840